Synlico Inc

Synlico Inc, based in Burlingame, CA, is at the forefront of integrating biology, artificial intelligence, and single-cell bioinformatics to revolutionize drug discovery and development. Their mission focuses on creating potent therapies tailored to the complexities of disease microenvironments by identifying causal links between cellular activities and patient responses.

The company's innovative approach addresses critical issues in drug design, such as discrepancies between lab results and patient responses, through a targeted and predictive AI platform. With a team of experts, Synlico is dedicated to making cellular processes quantitatively explainable, predictable, and engineerable, thereby paving the way for advanced therapeutic solutions.

Generated from the website